INATAL Ultra (Nnodum Pharmaceuticals)


Welcome to the PulseAid listing for the INATAL Ultra drug offered from Nnodum Pharmaceuticals. This Vitamin A [Chemical/Ingredient],Vitamin A [EPC],Calcium [Chemical/Ingredient],Calcium [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA],Vitamin D [Chemical/Ingredient],Vitamin D [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Copper [Chemical/Ingredient],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Nnodum Pharmaceuticals
NON-PROPRIETARY NAME: INATAL Ultra
SUBSTANCE NAME: VITAMIN A; ASCORBIC ACID; CALCIUM CITRATE; IRON PENTACARBONYL; CHOLECALCIFEROL; ALPHA-TOCOPHEROL ACETATE; THIAMINE MONONITRATE; RIBOFLAVIN; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; FOLIC ACID; CYANOCOBA
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Vitamin A [Chemical/Ingredient],Vitamin A [EPC],Calcium [Chemical/Ingredient],Calcium [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA],Vitamin D [Chemical/Ingredient],Vitamin D [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Copper [Chemical/Ingredient],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET, COATED
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2005-06-20
END MARKETING DATE: 0000-00-00


INATAL Ultra HUMAN PRESCRIPTION DRUG Details:

Item DescriptionINATAL Ultra from Nnodum Pharmaceuticals
LABELER NAME: Nnodum Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 2700; 120; 200; 90; 400; 30; 3; 3.4; 20; 20; 1; 12; 150; 25; 2; 50([iU]/1; mg/1; mg/1; mg/1; [iU]/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; ug/1; mg/1; mg/1; mg/1)
START MARKETING DATE: 2005-06-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63044-154_4b22195d-d683-4ced-ae90-2aa395765bf8
PRODUCT NDC: 63044-154
APPLICATION NUMBER:

Other VITAMIN A; ASCORBIC ACID; CALCIUM CITRATE; IRON PENTACARBONYL; CHOLECALCIFEROL; ALPHA-TOCOPHEROL ACETATE; THIAMINE MONONITRATE; RIBOFLAVIN; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; FOLIC ACID; CYANOCOBA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Nnodum PharmaceuticalsINATAL Ultra